Serum is the most common and easily accessible patient specimen in a minimally invasive manner.
Introduction
In many clinical situations, viral infection is frequently suspected as an etiological factor.
Yet unless there is an explicit viral candidate, the confirmation of putative viral infections is a difficult task. For instance, approximately 20% of human tumors are estimated to be associated with viral infection, however, only a very small subset of human tumors have been established as having a causal link with known viral infection [1] . Such a gap largely results from the frustration in discovering candidate viruses epidemiologically related to a given disease phenotype, which represents the first step in terms of a causal disease link. Historically viral categorization and discovery is essentially a technology-driven process. When candidate viruses are not readily grown in vitro, the detection of virus-encoded products or viral genomes becomes the only choice. In this setting, many methods have been developed with a focus on the utilization of high throughout molecular techniques, such as immune-based library screening [2] , mass spectrometry [3] , microarray [4] and next-generation sequencing (NGS) [5] [6] [7] [8] . Among them NGS represents the most attractive approach due to its large dynamic detection range and the independence of any viral sequence information [9, 10] , which is particularly important for the discovery of novel viruses.
Indeed, by taking advantage of complete decipherment of human genome sequences, a NGS-based approach, named transcriptome subtraction or digital subtraction, had been developed and achieved initial success [5, 11] . However, most studies, if not all, use human tissues as a starting biological source. In practice, tissue is not readily accessible or feasible in situations where there is no explicit target for a suspicious viral infection. Similarly, in a "hit and run" infection mode [12] , there may be only a transient viremia and thus a very narrow time window for tissue sampling. In addition, post-NGS analysis is often technically challenging and thus limits its application [13] . In studies of Page 4 viral categorization and discovery, it is desirable for each sequencing read to have a clear origin and thus to maximize opportunity for detection of putative viruses. However, this point is currently considerably compromised, in particular being the lack of computationally efficient pipelines [5] [6] [7] [8] [9] .
In the current study, through the integration of recent advances in bioinformatic tools, we present a robust, sensitive and simplified NGS-based method that uses human serum as a biological source for viral categorization and discovery.
Materials and Methods

Ethical Statement
This study used patient serum samples for the development of a new methodology with regard to viral categorization and discovery in human circulation. For collection of serum samples from patients, a written informed consent was obtained from each participant. The consent was documented by subject signature and signature of person obtaining consent on the Saint Louis University Institutional Review Board (IRB) approved consent form. The Saint Louis University IRB, an Independent Ethics Committee (IEC) reviewed and approved the consent form and consent process.
Serum samples
Hepatitis C virus (HCV), one of the medically important RNA viruses, consists of a single stranded RNA genome approximately at 9600 base pairs [14] . HCV circulates in patient blood at low titer that commonly requires a nested PCR procedure after reverse transcription (RT) for clinical Page 5 diagnosis [15] . In the current study, HCV was used as a model viral agent for both the optimization and validation of experimental protocols.
Serum sample #1709, from our previous study that estimated the role of HCV quasispecies in the antiviral therapy [16] , was available at large volume that allowed extensive experimental optimization. It had an HCV RNA level of 3.2 x 10 6 IU/mL (approximately equal to 3 x 10 6 copies/mL) as determined by Roche Amplicor HCV Monitor (version 2.0). Additional serum samples, either HCV-negative or positive, were collected from patients at the Saint Louis University Hospital liver clinic with a protocol approved by the Saint Louis University IRB. These samples were used for either serum RNA quantitation or the verification of experimental procedures. All serum samples were stored at -80 0 C until use.
Measurement of serum RNA concentration
Total RNA was extracted from 140 L serum and eluted into 60 L Tris buffer (pH8.5) using
QIAamp Viral RNA Mini kit (Qiagen, Valencia, CA). RNA concentration was measured with Qubit RNA BR Assay Kit in the Qubit 2.0 Fluorometer (Life Technologies, Grand Island, NY).
The measurement for each RNA sample was repeated three times and the mean values were used to calculate total RNA concentration in corresponding serum samples.
Unbiased cDNA amplification from serum samples
Common NGS platforms, such as Illumina's HiSeq2000 and Roche's GS/FLX, require a minimum DNA input at microgram grade. An amplification step after RT is thus necessary prior to NGS. In this setting, there are no existing protocols that demonstrate an unbiased amplification from extracted serum RNA, an extremely heterogeneous sample type. In the current study, such an unbiased amplification was achieved through extensive optimization.
Strategy for optimization
A two-step strategy was exploited to minimize labor/cost during the optimization. The first step was to determine the best approach that deserved further optimization. The second step aimed to a continuous optimization of unbiased amplification and the simplification of experimental protocols.
Approaches for unbiased serum cDNA amplification
A total of six experimental approaches, including two commercial kits, were empirically decided to estimate their ability for an unbiased amplification of serum cDNA ( Figure 1 The RT product was used either for multiple displacement amplification (MDA) (approach 1) or random PCR (approach 2) (Figure 1 ). The MDA was conducted in a 50-L reaction volume consisting of 5 L RT product, 1x phi29 DNA polymerase reaction buffer, 1 mM dNTPs, 30 U of phi29 DNA polymerase (New England Biolabs). The reaction was incubated at 30 0 C for 12 hours, followed by inactivation at 65 0 C for 15 minutes.
In random PCR approach, entire RT product was mixed with 30-L PCR matrix containing Approaches #3 and #4 were respectively similar to #1 and #2 except for the omission of RNA ligation step ( Figure 1 ). Two commercial kits, QuantiTect Whole Transcriptome Kit (Qiagen) and WTA2 Kit (Sigma, St. Louis), were also included for the estimation of unbiased cDNA amplification. The major experimental steps were outlined ( Figure 1 ) and their performance was basically according to instructions from the manufacturers.
Selection of the best approach for next-step optimization
The detection of HCV non-translated domain (5'UTR) in final product was used as an indicator for the feasibility of each approach described above. Briefly, an aliquot of 2 L 1:10 diluted final product from each approach was used as the template in a 30-cycle single-round PCR that contained 1.2 mM Mg(OAc)2, 1x rTth, XL buffer, 0.8 mM dNTPs, 0.4 mM of primers QUF3 and QUR3 (Table S1) 
Optimization of RT/MDA
Based on the selection criteria, the RT/MDA protocol (approach 3) was subjected to second-round optimization for an unbiased amplification of all components in serum RNA samples, as indicated by simultaneous detection in their final products for four HCV genes over entire HCV genome, i.e., 5' NTR, Core, NS3 and NS5a (Table S1 ). Experimental optimization focused on the adjustment of three major parameters, including time length (from 4 to 22 hours) of MDA incubation, primer concentrations and reaction buffers.
Pyrosequencing
Using the optimized RT/MDA protocol, 10 L of extracted serum RNA was used as starting material for cDNA amplification in sample #1709 and additional two HCV-negative samples, #5664 and #5880 that were mainly used for estimating the role of input RNA concentrations on the composition of read libraries. A negative control (water) was also included. The RT/MDA product was purified using QIAamp DNA Mini Kit (Qiagen) and quantified by Qubit Fluorometer (Invitrogen). An aliquot of 5 g RT/MDA product from each sample and the control was used for shotgun library construction and then subjected to pyrosequencing on Roche 454 GS/FLX Titanium platform.
Determination of consensus HCV genome sequence from sample #1709
A nearly full-length HCV genome (9022 bp) was amplified from sample #1709 by a long RT-PCR technique (LRP) [18, 19] . An aliquot of 5 g gel-purified LRP product was used for the construction of fragment library with Rapid Library Preparation Kit (Roche Applied Science), followed by pyrosequencing on GS/FLX Titanium platform. Resulting sequencing reads were assembled to generate the consensus sequence by reference mapping to H77 sequence (GenBank accession number: AF009606) in 454 software (Newbler, v2.6).
Sequence analysis
Data quality control
Raw sequencing reads from each sample and the control were filtered in program PRINSEQ (v0.19.5) [20] for quality control, including read length (≤50 bp), mean read quality score (≤25), low complexity with DUST score ≥7 [21] and ambiguous bases (≥1%) [22] . PRINSEQ was also used for basic read statistics such as the distribution of read length, quality score, GC content and Page 10 overall data pattern by principal component analysis (PCA) [20] . Filtered reads were first examined for their categories and abundance in terms of genetic origin, which was conducted with gapped aligner Bowtie 2 [23] against numerous databases, including human genome UCSC hg19 [24] , human cDNA and non-coding RNA (Ensemble release 69) [25] , microRNA (mature and hairpin) (release 19) [26] , human repetitive DNA elements (RepBase, v17.11) [27] , NCBI reference sequences (bacteria, 7.6 GB; virus, 94.4 MB, fungi 3.2 GB) [28] and an in-house human tRNA/rRNA collection (3771 sequences) made from UCSC human genome and SLIVA [29] .
Viral categorization
The categorization of known viruses utilized NCBI virus reference database consisting of 4,352 entire viral genomes in its most recent release. An enrichment strategy was applied to minimize false positive detection while dramatically increasing detection sensitivity. In doing so, mapping stringency was gradually increased in Bowtie 2 aligner through a functional score setting f(x) = n + 8ln(x) where "x" indicated the read length and "n" was adjusted from 20 (default setting) to 120 by a "10" interval. Read hits from individual virus genome were counted at each score setting in SAM output through either SAMtools (idxstats) [30] or BEDTools [31] . Declining rates of read hits for each mapped viral genome were then calculated against the baseline scoring setting (default setting), which generated a declining map of all mapped read hits for viral categorization. Under the highest mapping score setting, i.e., f(x) = 120 + 8ln(x)], a long read at 800 bp requires score at least 173.4 for efficient mapping, which is equal to 87-bp complete match or extended lengths with penalty from mismatches [23] . Assuming a cutoff value >0 at the highest score setting, the detection of a given virus by our enrichment strategy thus depends on the availability of at least one read hit in mapping at the highest score setting.
Approach to viral discovery
For discovery of possible new viruses, unmapped reads were obtained through successive subtraction against human hg19, human cDNA, bacteria, known virus, fungi and the control library as described above. Reads with >95% sequence identity were further removed by cd-hit-454 [32] .
These reads were first examined and filtered for hits in NCBI "nr" protein sequence database by BLASTX with an empirical E value setting at 0.001 [33] . Next, all open reading frames (ORFs) longer than 50 amino acids in six frames were extracted from remaining reads by EMBOSS getorf module [34] , followed by the scanning for protein signatures using InterProScan (v5RC4) [35] against the InterPro protein family database, including PROSITE, PRINTS, Pfam, ProDom, SMART, TIGRFAMs, PIR SuperFamily and Superfamily [36] . All resulting ORFs were analyzed by BLASTP with E value at 0.01 against NCBI viral protein database made by MAKEBLASTDB program. PSI-BLAST was used as the final step to find evolutionally distant viral relatives in final set of ORFs [33] . Alternatively, unmapped reads were directly used for ORF extraction, followed by BLASTP and PSI-BLAST analyses against viral protein database ( Figure S1 ).
Data availability
The consensus HCV genome sequence presented in sample #1709 was deposited in GenBank with accession number JX472007. Raw sequence data from three samples and the control were archived in NCBI under SRA accession number SRA065358.
Results
Unbiased amplification of serum total RNA molecules
Hepatitis C virus (HCV as an internal reference gene for unbiased amplification
QIAamp Viral RNA Mini kit (Qiagen) is commonly used for total RNA extraction with a high recovery rate (>90%) of RNA molecules large than 50 bp [37] . 
Robust and reproducible amplification
The simplified RT/MDA protocol gave a robust amplification of all serum samples with yields in microgram quantities ( Figure 2 ). The strong strand-displacement activity of phi29 DNA polymerase made final products to form a dominant hyper-branched structure at about 20 kb (Fig   2) . Such a product was even observed in the blank control (water) (Figure 2 ), representing the artifacts from the polymerization of hexamer dimers by phi29 DNA polymerase that was reported to bind and initiate polymerization of as little as 4 bp of oligonucleotide in spite of a less stable status [38] . Indeed, the product from the negative control was completely eliminated when setting the temperature of MDA at 34 0 C (data not shown). However, raising the temperature for MDA above 30 0 C resulted in a dramatic decrease of final product yield.
Data overview
Sequencing reads from three samples showed consistent patterns in terms of GC content and data patterns ( Figure S2 ). Sample #1709 had average read length at 413.9 bp that was longer than the other libraries (Table S2) , perhaps due to batch-to-batch differences in library preparation and pyrosequencing. The negative control had almost negligible mapping rates against all databases ( Figure 3 ). As expected, individual database mapping revealed the dominance of reads as being of human origin in each patient sample, however, a small but significant part of the reads could be mapped to microbes (Figure3). The comparison of mapping rates between human and microbes indicated that at least a subset of reads were chimeric due to strand-displacement activity of phi29 DNA polymerase [39] . A cross-mapping against the negative control also showed the occurrence of reads representing primer artifacts. As consistent with previous reports, the numbers of these artifacts seemed dependent on serum RNA concentrations with the highest amount found in sample #1709 (Table S2 ) [40] . It was interesting to note that none of the reads from the negative control were mapped to an in-house database (10 GB) simulated by random permutation of 4096 (4 6 ) hexamers in Biopython [41] . The generation of primer artifacts is thus not a random event under fixed RT/MDA procedure. Finally, after the exclusion of reads mapped to the negative control, read duplicates were higher in #1709 than samples #5664 and #5880, which was commonly found in metagenomic data and believed to be associated with sequence depths [32] .
Categorization of known viruses
Viral categorization was done by direct read mapping against NCBI virus database using gapped aligner Bowtie 2 [23] . Because of chimeric or multi-mapped reads, Bowtie 2 was run under "-a" mode that reported all alignments under defined score settings. The mapping under the default score setting identified 342 viruses with read hits ranging from 1 to 9085 in sample #1709. This impractically large number reflected the sequence similarity between humans and microbes as the consequence of long-term co-evolution [42] . To eliminate false positive detection, an enrichment strategy was applied by modulating the mapping stringencies. In sample #1709, enrichment with a cutoff >0 at the highest score setting returned 23 viruses, including six major HCV genotypes, eleven Torque teno virus (TTV) subtypes and four phages (Figure 4) . TTV was also a major virus in circulation in samples #5664 and #5880, as revealed by similar enrichment analysis ( Figure S3 ).
It should be noted that sequence similarity among viruses should be taken into account in final data interpretation. For a given virus, NCBI virus reference database includes its major serotypes or genotypes. These serotypes or genotypes may be all recruited during mapping due to sequence homology, as seen for HCV and TTV in case of sample #1709 (Figure 4 ). Thus the current categorization strategy cannot resolve viral isolates at serotype or genotype level. Further determination of viral serotypes or genotypes requires phylogenetic analysis of individual reads.
In sample #1709, a total of seven HCV-related reads were retrieved. These reads, ranging from 147 bp to 473 bp, covered nearly 26% of the HCV genome ( Figure S4 ). All HCV reads were identical to the HCV consensus sequence derived through HCV LRP amplicon pyrosequencing, supporting a high fidelity nature of phi29 DNA polymerase [43] .
Discovery of novel viruses
Using the data from ample #1709, a step-wise pipeline was developed for the discovery of potential novel viruses. First, subtractive mapping was performed in Bowtie 2 under the higher stringency than the default setting, f(x) = 30 + 8ln(x), which reserved as much as sequence information for downstream analysis. There were 27,984 reads remained after successive database-based subtraction from human DNA, human cDNA, NCBI microbe reference sequences (bacteria, virus and fungi) and primer artifacts from the control. Next, read number was reduced to 14,474 after the removal of duplicates by CD-hit-454 (95% identity) [32] and length exclusion by PRINSEQ (>100 bp) [20] . Among these 14,474 reads, 10,846 (74.9%) reads had at least one hit by BLASTX in all six frames against NCBI "nr" non-redundant protein database. By combination, these reads actually targeted 2,793 proteins, mostly from bacteria (Table S3 ). The only virus-related hits were from Page 16 TTV (Table S3) . It was interesting to note that the most frequent hits came from Pseudomonas sp.
that was assumed as a common contaminant in phi29 DNA polymerase preparation (Table S3) [44].
For remaining 3,628 reads, a total of 14,540 ORFs longer than 50 amino acids were extracted in all six frames using EMBOSS getorf script [34] . These ORFs were scanned for protein ORFs got protein hits mostly associated with phages. One ORF was found to be relevant to human T-lymphotropic virus and thus warranted further investigation.
Discussion
The current study systematically documented an integrated approach for viral categorization and discovery from human circulation. The approach represents a unique platform in terms of its starting material and analysis pipeline. First, using HCV as a model agent, unbiased amplification of minute amounts of serum RNA was achieved by optimized RT/MDA, supporting a general observation that MDA outperforms PCR-based amplification in terms of fidelity and linear characteristics [45, 46] . with a defined mapping stringency were exported for downstream enrichment, which not only eliminated false positive detection due to sequence similarity but also maximized the detection sensitivity. In this setting, it should be noted there are two special cases in which viruses have exceptional sequence similarity with the human genome, including bovine viral diarrhea virus 1/pestivirus Giraffe-1 and murine osteosarcoma virus respectively due to an insertion of cellular sequences and the existence of cellular homolog, respectively [47, 48] . These viruses should be removed from the list of viral categorization as seen in sample #1709 (Figure 4 ). Under our enrichment strategy, any known viruses with a single read representation in entire NGS data can be reliably detected. The feasibility of viral categorization was validated in three serum samples, including sample #1709 with known HCV infection. All three samples had TTV infection that was confirmed by subsequent PCR (data not shown).
In viral discovery, digital sequence subtraction was achieved by direct subtractive mapping in Bowtie 2. Unmapped reads were analyzed by conventional BLASTX against NCBI "nr", a nonredundant protein database. Remaining reads were then searched for protein signature in InterProScan, followed by BLASTP analysis against NCBI viral protein database. Finally, PSI-BLAST analysis provided evolutionary indication of potential novel viral reads. Alternatively, unmapped reads could be directly used for BLASTP analysis after the extraction of all possible ORFs ( Figure S1 ). The latter represents a more computationally efficient approach due to the omission of BLASTX, which is frequently a bottleneck in the processing of large NGS data. As exemplified with sample #1709, viral discovery with either approach could be resolved at the single read level. We also applied these approaches to analyze two 454 libraries that resulted in the discovery of Merkel Cell polyomavirus (MCV) [5] . Three viruses detected by viral categorization represent special cases of exceptional sequence similarity as discussed above ( Figure S5 ).
Subtractive mapping respectively identified 469 and 770 unmapped reads for libraries SID3154 and SID3155, from which 150 and 144 ORFs were extracted, respectively. By direct BLASTP analysis against NCBI viral protein database in which MCV was omitted intentionally, three reads had statistically significant hits. Of these, two reads (ERV7PKU01C5JYE and ERV7PKU01BLS7V) encoded a protein product corresponding to large T antigen of polymavirus (Table S4) . Giving intrinsic heuristic algorithms [49] , BLASTP analysis against a small database (NCBI virus reference database) is thus a rapid and more sensitive method to identify virus-relevant reads.
It should be noted that either viral categorization or discovery is a qualitative rather than quantitative method due to low coverage of viral genomes. While all four HCV regions were detected in the RT/MDA product from sample #1709, only 26% of the HCV genome was covered by resulting HCV-specific reads. This low genome coverage may be improved by increasing sequencing depth, which is now easily satisfied in a cost-effective manner by switching into Illumina's sequencing by synthesis (SBS) technology, such as HiSeq platform [50] . Another option is the increase of input RNA amount at RT/MDA, which seemed to be associated with the formation of primer artifacts (Table S2 ). These primer artifacts reduced the yield of target RNA molecules and also took a significant part of duplicate reads (Table S2 ). Finally, technical replicates, in particular under a shallow sequencing depth, are recommended for reliable viral categorization and discovery since RNA-Seq is essentially a sampling procedure [51] .
Serum RNA appears to show considerably stability at appropriate storage conditions and should attract increasing attention as a biological resource for clinical diagnostics [52] [53] [54] . We observed an efficient amplification of nearly full-length HCV genome from serum samples archived more than 10 years [18] . More importantly, serum is easily accessible in a minimally invasive manner. Using serum RNA as starting material, the present study has documented a technical platform for efficient categorization of both RNA (e.g. HCV) and DNA viruses (e.g. TTV) and viral discovery resolved at single-read level. The robust single-tube amplification and advanced bioinformatic tools, in combination with well-curated databases, allow this platform to be of immediate application in any clinical situations concerning an unknown viral infection. 
